A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System
1 other identifier
interventional
56
1 country
3
Brief Summary
The purpose of this study is to evaluate hair reduction in the underarms in patients treated with the miraDry System.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 19, 2012
CompletedFirst Posted
Study publicly available on registry
November 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedApril 1, 2016
March 1, 2016
2.2 years
November 19, 2012
March 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients with successful hair reduction
Percentage of patients that show a \>=30% reduction in underarm hair at the 3 month visit compared to baseline.
3 months
Secondary Outcomes (1)
Patients with successful hair reduction
12 months
Other Outcomes (1)
Patient satisfaction with hair reduction
All follow-up visits through 12 months
Study Arms (1)
Single Group miraDry Treatment
EXPERIMENTALThis is a single group study where each enrolled subject will receive active miraDry treatment in each axilla.
Interventions
Application of electromagnetic energy to heat the lower dermis.
Eligibility Criteria
You may qualify if:
- years of age
- Visible underarm hair (prefer light colored hair; blonde, red, gray)
You may not qualify if:
- Secondary Axillary Hyperhidrosis
- Prior surgery and/or Botox Injections in axillae
- Pacemaker or requires supplemental oxygen
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Miramar Labslead
Study Sites (3)
Zel Skin and Laser Specialists
Edina, Minnesota, 55424, United States
Laser & Skin Surgery Center of NY
New York, New York, 10016, United States
Lehigh Valley Dermatology
Bethlehem, Pennsylvania, 18017, United States
Study Officials
- STUDY DIRECTOR
Kathy Quiroz, BS, RN
Miramar Labs, Inc
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2012
First Posted
November 22, 2012
Study Start
September 1, 2012
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
April 1, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share